Page last updated: 2024-10-26

donepezil and Encephalopathy, Toxic

donepezil has been researched along with Encephalopathy, Toxic in 5 studies

Donepezil: An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE.
donepezil : A racemate comprising equimolar amounts of (R)- and (S)-donepezil. A centrally acting reversible acetylcholinesterase inhibitor, its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine.
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one : A member of the class of indanones that is 5,6-dimethoxyindan-1-one which is substituted at position 2 by an (N-benzylpiperidin-4-yl)methyl group.

Research Excerpts

ExcerptRelevanceReference
"Donepezil is a potent and selective acetylcholinesterase (AChE) inhibitor developed for the treatment of Alzheimer's disease."1.32Nicotinic acetylcholine receptor-mediated neuroprotection by donepezil against glutamate neurotoxicity in rat cortical neurons. ( Akaike, A; Kaneko, S; Katsuki, H; Kume, T; Sugimoto, H; Takada, Y; Yonezawa, A, 2003)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shaik, JB1
Palaka, BK1
Penumala, M1
Kotapati, KV1
Devineni, SR1
Eadlapalli, S1
Darla, MM1
Ampasala, DR1
Vadde, R1
Amooru, GD1
Takada, Y1
Yonezawa, A1
Kume, T1
Katsuki, H1
Kaneko, S1
Sugimoto, H1
Akaike, A1
Janowsky, DS1
Davis, JM1
Overstreet, DH1
Creeley, CE1
Wozniak, DF1
Nardi, A1
Farber, NB1
Olney, JW1
Duysen, EG1
Li, B1
Darvesh, S1
Lockridge, O1

Other Studies

5 other studies available for donepezil and Encephalopathy, Toxic

ArticleYear
Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents.
    European journal of medicinal chemistry, 2016, Jan-01, Volume: 107

    Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Antioxidants; Binding Sites; Butyrylcholinesterase

2016
Nicotinic acetylcholine receptor-mediated neuroprotection by donepezil against glutamate neurotoxicity in rat cortical neurons.
    The Journal of pharmacology and experimental therapeutics, 2003, Volume: 306, Issue:2

    Topics: Animals; Apoptosis; Cells, Cultured; Cerebral Cortex; Donepezil; Drug Antagonism; Glutamic Acid; Ind

2003
Antagonism of anticholinesterase (DFP) toxicity by donepezil plus scopolamine: a preliminary study.
    Pharmacology, biochemistry, and behavior, 2004, Volume: 77, Issue:2

    Topics: Animals; Behavior, Animal; Body Temperature; Cholinesterase Inhibitors; Diarrhea; Donepezil; Drug In

2004
Donepezil markedly potentiates memantine neurotoxicity in the adult rat brain.
    Neurobiology of aging, 2008, Volume: 29, Issue:2

    Topics: Animals; Behavior, Animal; Brain; Cell Death; Cholinesterase Inhibitors; Donepezil; Dose-Response Re

2008
Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
    Toxicology, 2007, Apr-20, Volume: 233, Issue:1-3

    Topics: Acetylcholine; Acetylcholinesterase; Alkaloids; Alzheimer Disease; Animals; Butyrylcholinesterase; C

2007